NKTX
Nkarta Inc
NASDAQ: NKTX · HEALTHCARE · BIOTECHNOLOGY
$2.69
-2.89% today
Updated 2026-04-29
Market cap
$201.75M
P/E ratio
—
P/S ratio
1,000,000.00x
EPS (TTM)
$-1.41
Dividend yield
—
52W range
$2 – $4
Volume
0.8M
Nkarta Inc (NKTX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-28.90%
ROA
-16.00%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2018 | $6.55M | $-274503.00 | 35.08% | -5.44% | -4.19% |
| 2019 | $115385.00 | $-21.08M | 85.08% | -19,368.66% | -18,265.66% |
| 2020 | $385.00 | $-91.36M | -272,207.79% | -13,378,701.30% | -23,730,129.87% |
| 2021 | $0.00 | $-83.95M | — | — | — |
| 2022 | $0.00 | $-119.42M | — | — | — |
| 2023 | $0.00 | $-117.50M | — | — | — |
| 2024 | $0.00 | $-108.79M | — | — | — |
| 2025 | $0.00 | $-104.08M | — | — | — |